Trademark: 88607972
Status Date
Tuesday, November 14, 2023
Registration Number
7215616
Registration Date
Tuesday, November 14, 2023
Filing Date
Friday, September 6, 2019
Published for Opposition
Tuesday, January 3, 2023
1 Nucleic acid sequences as reagents for use in genetic research, other than for medical or veterinary purposes; nucleic acids for scientific purposes, chemical compositions and materials in the nature of chemicals for use in genotyping, all as chemicals for use in industry; reagents, enzymes, chemical compositions, chemical primers and chemical probes for use in the manufacture of pharmaceuticals; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; nucleic acid sequences known as probes for use in signal amplification for use in the manufacture of diagnostic reagents for scientific or medical research use; nucleic acid sequences known as probes for use in signal amplification techniques for use in the pharmaceutical industry; nucleic acid sequences known as probes for use in detecting nucleic acids for raw material in the manufacture of pharmaceuticals; nucleic acid sequences known as probes for use in detecting mRNA directly without synthesizing cDNA for use as a raw material in the manufacture of diagnostic reagents; nucleic acid sequences known as probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use as a raw material in the manufacture of diagnostic reagents for scientific or research use; nucleic acid sequences known as probes for use in forming self-assembly honeycomb structure for use as an ingredient in pharmaceuticals; nucleic acid sequences known as probes for use in quantifying intact drug and parent drug fragment for use as an ingredient in diagnostic reagents; nucleic acid sequences known as probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for an ingredient in diagnostic reagents for scientific or medical research; nucleic acid sequences known as probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for as diagnostic reagents for scientific or medical research use; nucleic acid sequences known as probes for use in quantifying using samples from blood, tissue and cell lysates for use in cell cultures other than for medical or veterinary use; nucleic acid sequences known as probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for diagnostic reagents and preparations, except for medical or veterinary use; nucleic acid sequences known as probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes for use in self-assembly reactions for as reagents for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes to be used as signal amplifier for use in industry to detect nucleic acids; nucleic acid sequences known as probes for use in analyzing samples without using PCR for use in industry to detect mRNAs; biochemical reagents commonly known as probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; self-assembly formed by a short DNA probe pair for use in industry utilizing technology of DNA self-assembly reactions
Nov 14, 2023
Notice Of Registration Confirmation Emailed
Nov 14, 2023
Registered-Principal Register
Oct 12, 2023
1(B) Basis Deleted; Proceed To Registration
Aug 28, 2023
Notice Of Allowance Cancelled
Aug 28, 2023
Teas Post Publication Amendment Received
Feb 28, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 3, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2023
Published For Opposition
Dec 14, 2022
Notification Of Notice Of Publication E-Mailed
Nov 28, 2022
Approved For Pub - Principal Register
Oct 25, 2022
Teas/Email Correspondence Entered
Oct 25, 2022
Correspondence Received In Law Office
Oct 25, 2022
Assigned To Lie
Sep 19, 2022
Assigned To Lie
Sep 14, 2022
Assigned To Lie
Sep 6, 2022
Teas Response To Suspension Inquiry Received
Mar 31, 2022
Notification Of Letter Of Suspension E-Mailed
Mar 31, 2022
Letter Of Suspension E-Mailed
Mar 31, 2022
Suspension Letter Written
Mar 21, 2022
Teas/Email Correspondence Entered
Mar 21, 2022
Correspondence Received In Law Office
Mar 10, 2022
Teas Response To Suspension Inquiry Received
Sep 13, 2021
Suspension Checked ¿ To Attorney For Action
Sep 10, 2021
Notification Of Inquiry As To Suspension E-Mailed
Sep 10, 2021
Inquiry To Suspension E-Mailed
Sep 10, 2021
Suspension Inquiry Written
Feb 4, 2021
Notification Of Letter Of Suspension E-Mailed
Feb 4, 2021
Letter Of Suspension E-Mailed
Feb 4, 2021
Suspension Letter Written
Feb 3, 2021
Examiner's Amendment Entered
Feb 3, 2021
Notification Of Examiners Amendment E-Mailed
Feb 3, 2021
Examiners Amendment E-Mailed
Feb 3, 2021
Examiners Amendment -Written
Aug 4, 2020
Notification Of Non-Final Action E-Mailed
Aug 4, 2020
Non-Final Action E-Mailed
Aug 4, 2020
Non-Final Action Written
Jul 16, 2020
Divisional Processing Complete
Jun 8, 2020
Divisional Request Received
Jul 15, 2020
Case Assigned To Intent To Use Paralegal
Jul 15, 2020
Teas/Email Correspondence Entered
Jul 15, 2020
Correspondence Received In Law Office
Jul 1, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 1, 2020
Teas Change Of Correspondence Received
Jul 1, 2020
Teas Change Of Owner Address Received
Jun 24, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 24, 2020
Teas Change Of Correspondence Received
Jun 24, 2020
Teas Change Of Domestic Representatives Address
Jun 24, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 24, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 24, 2020
Teas Change Of Owner Address Received
Jun 16, 2020
Assigned To Lie
Jun 8, 2020
Teas Response To Office Action Received
Jun 8, 2020
Teas Request To Divide Received
Jan 30, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 30, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 28, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 28, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 6, 2019
Notification Of Non-Final Action E-Mailed
Dec 6, 2019
Non-Final Action E-Mailed
Dec 6, 2019
Non-Final Action Written
Nov 23, 2019
Assigned To Examiner
Sep 23, 2019
New Application Office Supplied Data Entered
Sep 11, 2019
Teas Amendment Entered Before Attorney Assigned
Sep 11, 2019
Teas Voluntary Amendment Received
Sep 10, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
